Humatica advises Capvis on their recent investment in AMANN GIRRBACH

ndetails

Humatica AG was retained to advise Capvis on its majority investment in Austrian firm AMANN GIRRBACH AG, a pioneer in dental CAD/CAM technology. The firm is a leading innovator in the field and a full-service provider for digital dental prosthetics.

Humatica provided organisational due diligence services for this transaction.

To view press release: Humatica advises Capvis on their recent investment in AMANN GIRRBACH

Related News

Experienced Private Equity executive Melissa Mounce joins Humatica to build the firm’s presence in the US
17 Feb., 2025 By Humatica

Experienced Private Equity executive Melissa Mounce joins Humatica to build the firm’s presence in the US

Humatica, the leading private equity specialist advisor for organizational effectiveness, is pleased to announce that Melissa Mounce has joined the firm as an Operating Partner…

Read more arrowicon
Humatica finalist for two prestigious PE Awards
03 Feb., 2025 By Humatica

Humatica finalist for two prestigious PE Awards

Humatica has been named a finalist for the Actum Awards as Value Creation Firm of the Year (People and Organisational Strategy) and for the Real Deals Private Equity Awards 2025 in…

Read more arrowicon
Humatica 2024 in Review and Outlook 2025
17 Dez., 2024 By Humatica

Humatica 2024 in Review and Outlook 2025

2024 was a milestone year for private equity, and for Humatica. The industry is under greater pressure to generate acceptable returns than ever before. With…

Read more arrowicon